Prophylaxis, empirical, preemptive therapy in presumed aspergillosis in hematolological patients: which strategy?

被引：0
|
作者：
Maschmeyer, G. [1 ]
机构：
[1] Klinikum Ernst Von Bergmann, Potsdam, Germany
来源：
MYCOSES | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 48 条
  • [1] Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy
    Herrera, Sabina
    Davoudi, Setareh
    Farooq, Ali
    Tikkanen, Jussi
    Foroutan, Farid
    Kumar, Deepali
    Humar, Atul
    Rotstein, Coleman
    Singer, Lianne G.
    Keshavjee, Shaf
    Husain, Shahid
    TRANSPLANTATION, 2020, 104 (12) : 2575 - 2581
  • [2] Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?
    Leather, HL
    Wingard, JR
    CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (04) : 369 - 375
  • [3] Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation
    Gerna, Giuseppe
    Lilleri, Daniele
    Callegaro, Annapaola
    Goglio, Antonio
    Cortese, Serena
    Stroppa, Paola
    Torre, Giuliano
    TRANSPLANTATION, 2008, 86 (01) : 163 - 166
  • [4] Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy
    Hoenigl, Martin
    Seeber, Katharina
    Koidl, Christoph
    Buzina, Walter
    Woelfler, Albert
    Duettmann, Wiebke
    Wagner, Jasmin
    Strenger, Volker
    Krause, Robert
    MYCOSES, 2013, 56 (04) : 471 - 476
  • [5] Cytomegalovirus Treatment Strategy After a Liver Transplant: Preemptive Therapy or Prophylaxis for Cytomegalovirus Seropositive Donor and Recipient
    Lindner, Kirsten
    Anthoni, Christoph
    Beckebaum, Susanne
    Senninger, Norbert
    Hoelzen, Jens Peter
    Wolters, Heiner
    Experimental and Clinical Transplantation, 2016, 14 (04) : 419 - 423
  • [6] Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection
    DiNubile, Mark J.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 808 - U168
  • [7] Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection Reply
    Srasuebkul, Preeyaporn
    Sungkanuparph, Somnuek
    Lim, Poh Lian
    Law, Matthew G.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 811 - U170
  • [8] Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients Treated with a Preemptive/Targeted Antifungal Therapy Strategy: 4 Year Follow Up
    Herrera, S.
    Farooq, A.
    Davoudi, S.
    Martinu, T.
    Kumar, D.
    Humar, A.
    Rotstein, C.
    Singer, L. G.
    Keshavjee, S.
    Husain, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S220 - S220
  • [9] Cost Effectiveness Analysis of Universal Prophylaxis Versus Preemptive Therapy in Kidney Transplant Patients with Positive Cytomegalovirus Serology
    Luan, Fu L.
    Kommareddi, Mallika
    Ojo, Akinlolu O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 126 - 126
  • [10] Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert, Miguel
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S149 - S153
12345